196 related articles for article (PubMed ID: 25766132)
1. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis.
Kashima S; Fujiya M; Konishi H; Ueno N; Inaba Y; Moriichi K; Tanabe H; Ikuta K; Ohtake T; Kohgo Y
Transl Res; 2015 Aug; 166(2):163-75. PubMed ID: 25766132
[TBL] [Abstract][Full Text] [Related]
2. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway.
Segawa S; Fujiya M; Konishi H; Ueno N; Kobayashi N; Shigyo T; Kohgo Y
PLoS One; 2011; 6(8):e23278. PubMed ID: 21858054
[TBL] [Abstract][Full Text] [Related]
3. 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling.
Loeuillard E; Bertrand J; Herranen A; Melchior C; Guérin C; Coëffier M; Aziz M; Déchelotte P; Savoye G; Marion-Letellier R
World J Gastroenterol; 2014 Dec; 20(48):18207-15. PubMed ID: 25561788
[TBL] [Abstract][Full Text] [Related]
4. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.
Flier SN; Tanjore H; Kokkotou EG; Sugimoto H; Zeisberg M; Kalluri R
J Biol Chem; 2010 Jun; 285(26):20202-12. PubMed ID: 20363741
[TBL] [Abstract][Full Text] [Related]
5. Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model.
Zhu MY; Lu YM; Ou YX; Zhang HZ; Chen WX
J Dig Dis; 2012 Aug; 13(8):421-9. PubMed ID: 22788928
[TBL] [Abstract][Full Text] [Related]
6. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.
Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J
Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis.
Wang R; Wang D; Wang H; Wang T; Weng Y; Zhang Y; Luo Y; Lu Y; Wang Y
Front Immunol; 2021; 12():670159. PubMed ID: 34456904
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.
Matsuura M; Okazaki K; Nishio A; Nakase H; Tamaki H; Uchida K; Nishi T; Asada M; Kawasaki K; Fukui T; Yoshizawa H; Ohashi S; Inoue S; Kawanami C; Hiai H; Tabata Y; Chiba T
Gastroenterology; 2005 Apr; 128(4):975-86. PubMed ID: 15825079
[TBL] [Abstract][Full Text] [Related]
9. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis.
Ding H; Gan HZ; Fan WJ; Cao LY; Xu JM; Mei Q
Dig Dis Sci; 2015 Feb; 60(2):375-81. PubMed ID: 25293822
[TBL] [Abstract][Full Text] [Related]
11. Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function.
Ueno N; Fujiya M; Segawa S; Nata T; Moriichi K; Tanabe H; Mizukami Y; Kobayashi N; Ito K; Kohgo Y
Inflamm Bowel Dis; 2011 Nov; 17(11):2235-50. PubMed ID: 21987297
[TBL] [Abstract][Full Text] [Related]
12. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.
Lawrance IC; Wu F; Leite AZ; Willis J; West GA; Fiocchi C; Chakravarti S
Gastroenterology; 2003 Dec; 125(6):1750-61. PubMed ID: 14724828
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
[TBL] [Abstract][Full Text] [Related]
14. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.
Nanda Kumar NS; Balamurugan R; Jayakanthan K; Pulimood A; Pugazhendhi S; Ramakrishna BS
J Gastroenterol Hepatol; 2008 Dec; 23(12):1834-9. PubMed ID: 19120873
[TBL] [Abstract][Full Text] [Related]
15. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model.
Park JS; Choi J; Kwon JY; Jung KA; Yang CW; Park SH; Cho ML
J Transl Med; 2018 Feb; 16(1):37. PubMed ID: 29466999
[TBL] [Abstract][Full Text] [Related]
16. Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels.
Wang S; Zhang S; Huang S; Wu Z; Pang J; Wu Y; Wang J; Han D
Biomed Res Int; 2020; 2020():7694734. PubMed ID: 33015180
[TBL] [Abstract][Full Text] [Related]
17. The effect of selected Lactobacillus strains on dextran sulfate sodium-induced mouse colitis model.
Hasannejad-Bibalan M; Mojtahedi A; Eshaghi M; Rohani M; Pourshafie MR; Talebi M
Acta Microbiol Immunol Hung; 2020 Jun; 67(2):138-142. PubMed ID: 32554841
[TBL] [Abstract][Full Text] [Related]
18. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis.
Marcon R; Bento AF; Dutra RC; Bicca MA; Leite DF; Calixto JB
J Immunol; 2013 Oct; 191(8):4288-98. PubMed ID: 24038091
[TBL] [Abstract][Full Text] [Related]
19. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis.
Walana W; Ye Y; Li M; Wang J; Wang B; Cheng JW; Gordon JR; Li F
Biomed Pharmacother; 2018 Jul; 103():253-261. PubMed ID: 29655167
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses.
Zhou FX; Chen L; Liu XW; Ouyang CH; Wu XP; Wang XH; Wang CL; Lu FG
World J Gastroenterol; 2012 May; 18(19):2344-56. PubMed ID: 22654425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
